Lumexa Imaging Holdings, Inc. (LMRI) vs PROCEPT BioRobotics Corporation (PRCT)

Lumexa Imaging Holdings, Inc. and PROCEPT BioRobotics Corporation are both Medical Devices companies. Lumexa Imaging Holdings, Inc. and PROCEPT BioRobotics Corporation are of similar size ($1.0B and $949.2M). Lumexa Imaging Holdings, Inc. has the higher net margin (−2.78% vs −32.5%) and the higher return on invested capital (48.1% vs −43.6%). Across the 16 metrics below, Lumexa Imaging Holdings, Inc. leads on 12 and PROCEPT BioRobotics Corporation on 4.

Valuation

Metric LMRI PRCT Medical Devices median
P/E n/m n/m 22.18
P/S 0.55 2.91 2.70
P/B 1.59 2.89 2.46
Price to free cash flow 65.63 n/m 22.53
EV/EBITDA 1.57 n/m 11.78
EV/Sales 1.00 2.39 2.38
Earnings yield (6.99%) (11.28%) (8.22%)
Free cash flow yield 1.52% (8.65%) (7.80%)

Profitability

Metric LMRI PRCT Medical Devices median
Gross margin 63.41% 64.22% 56.01%
Operating margin 61.03% (33.86%) (15.03%)
Net margin (2.78%) (32.54%) (20.40%)
Free cash flow margin 0.83% (25.17%) (7.24%)
Return on equity 0.00% (30.24%) (15.32%)
Return on assets (5.51%) (22.12%) (19.72%)
Return on invested capital 48.10% (43.57%) (10.33%)

Growth

Metric LMRI PRCT Medical Devices median
Revenue growth (TTM) — 22.69% 8.80%
EPS growth (last fiscal year) 51.01% 1.71% —
Revenue growth, 5-year CAGR — 109.04% 15.23%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric LMRI PRCT Medical Devices median
Debt to equity 1.42 0.15 0.07
Current ratio 1.44 6.55 2.50
Net debt to EBITDA 5.06 2.41 0.49

Dividend

Metric LMRI PRCT Medical Devices median
Dividend yield — — 0.94%
Payout ratio — 0.00 0.00

Size

Metric LMRI PRCT Medical Devices median
Market cap 949.22m 1.01b 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack